ABOS
Price
$1.04
Change
+$0.04 (+4.00%)
Updated
Jun 3 closing price
Capitalization
63M
75 days until earnings call
BEAM
Price
$17.03
Change
+$0.15 (+0.89%)
Updated
Jun 4, 11:16 AM (EDT)
Capitalization
1.7B
69 days until earnings call
Interact to see
Advertisement

ABOS vs BEAM

Header iconABOS vs BEAM Comparison
Open Charts ABOS vs BEAMBanner chart's image
Acumen Pharmaceuticals
Price$1.04
Change+$0.04 (+4.00%)
Volume$336.23K
Capitalization63M
Beam Therapeutics
Price$17.03
Change+$0.15 (+0.89%)
Volume$555
Capitalization1.7B
ABOS vs BEAM Comparison Chart
Loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABOS vs. BEAM commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a Buy and BEAM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2025
Stock price -- (ABOS: $1.04 vs. BEAM: $16.88)
Brand notoriety: ABOS and BEAM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 150% vs. BEAM: 63%
Market capitalization -- ABOS: $63M vs. BEAM: $1.7B
ABOS [@Biotechnology] is valued at $63M. BEAM’s [@Biotechnology] market capitalization is $1.7B. The market cap for tickers in the [@Biotechnology] industry ranges from $321.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whileBEAM’s FA Score has 1 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • BEAM’s FA Score: 1 green, 4 red.
According to our system of comparison, BEAM is a better buy in the long-term than ABOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 1 TA indicator(s) are bullish while BEAM’s TA Score has 3 bullish TA indicator(s).

  • ABOS’s TA Score: 1 bullish, 4 bearish.
  • BEAM’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than ABOS.

Price Growth

ABOS (@Biotechnology) experienced а +1.96% price change this week, while BEAM (@Biotechnology) price change was -0.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.76%. For the same industry, the average monthly price growth was +2.77%, and the average quarterly price growth was +0.74%.

Reported Earning Dates

ABOS is expected to report earnings on Aug 18, 2025.

BEAM is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+5.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.7B) has a higher market cap than ABOS($63M). BEAM YTD gains are higher at: -31.935 vs. ABOS (-39.535). ABOS has higher annual earnings (EBITDA): -77.89M vs. BEAM (-399.03M). BEAM has more cash in the bank: 1.22B vs. ABOS (200M). ABOS has less debt than BEAM: ABOS (28.5M) vs BEAM (158M). BEAM has higher revenues than ABOS: BEAM (63.6M) vs ABOS (0).
ABOSBEAMABOS / BEAM
Capitalization63M1.7B4%
EBITDA-77.89M-399.03M20%
Gain YTD-39.535-31.935124%
P/E RatioN/AN/A-
Revenue063.6M-
Total Cash200M1.22B16%
Total Debt28.5M158M18%
TECHNICAL ANALYSIS
Technical Analysis
ABOSBEAM
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 20 days ago
77%
Bullish Trend 1 day ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 6 days ago
85%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
81%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 1 day ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WGMVX4.060.05
+1.25%
Wasatch Micro Cap Value Institutional
TWGAX14.05N/A
N/A
American Century International Gr A
FAGOX175.40N/A
N/A
Fidelity Advisor Growth Opps M
EGWAX13.19N/A
N/A
Allspring Discovery Small Cap Gr Gr A
IVOAX18.30N/A
N/A
Macquarie Mid Cap Income Opps A

ABOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with FHTX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then FHTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
+4.00%
FHTX - ABOS
50%
Loosely correlated
+4.56%
BEAM - ABOS
49%
Loosely correlated
+4.26%
ALEC - ABOS
49%
Loosely correlated
+7.25%
ATOS - ABOS
49%
Loosely correlated
-1.68%
ABCL - ABOS
49%
Loosely correlated
+7.94%
More